Micro-Hall detector counts rare CTCs in clinical samples
from Genetic & Engineering Science News
Scientists have developed a miniaturized microfluidic chip–based technology that they claim could form the basis of a rapid, POC diagnostics platform for quantitatively measuring rare circulating tumor cells or pathogens in clinical samples. The micro-Hall detector essentially identifies individual target cells labeled with magnetic nanoparticles as they flow through the channels on a microfluidic chip.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063